Stryker has agreed to acquire medical technology maker Inari Medical in a deal worth $4.9 billion, the companies said ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Stryker (SYK) confirmed an agreement to purchase Inari Medical (NASDAQ:NARI) for about $4.9 billion. Inari jumped 21% in ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Irvine-based Inari Medical Inc. has entered into an agreement to be acquired for $4.9 billion by medical technology company ...

Medical device maker Stryker Corp. agreed to purchase Inari Medical Inc. for about $4.9 billion to expand its offerings in the fast-growing area of treating blood clots in the legs and lungs.

Stryker (SYK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Wood from Morgan ...

A deal for Inari, which has a market value of nearly $3 billion, would bolster Stryker’s efforts to build out its offerings ...

Inari Medical (NARI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Sarcone ...

Stryker is in advanced talks to acquire Inari Medical to enhance offerings for venous disease treatments. The deal, if successful, will strengthen Stryker's position in the medical device sector.

Stryker Corp. plans to pay $4.9 billion to acquire Inari Medical Inc., which makes devices to treat venous conditions.